Nearly half of all new cancer drugs approved by the U.S. Food and Drug Administration (FDA) over the past quarter-century ...
CapsoVision announced today that the FDA cleared its CapsoCam Plus system for use in pediatric patients aged two and above.
Prostate cancer that has become resistant to hormone therapy could be treated using a new drug that is currently in clinical ...
The U.S. FDA has provided advice for Tiakis Biotech's Phase 2 clinical trial of tiprelestat for pulmonary arterial ...
More than 1,300 pounds of cat food are being recalled due to Salmonella contamination, according to a notice from the U.S.
Medically reviewed by Elizabeth Barnes, RDN Optimizing cognitive health is top of mind for many adults, and there are many ...
A whole grain breaded broccoli nugget product has been recalled due to fears that it may contain metal.
In its last few days of power, the Biden administration is expected to officially propose a limit on nicotine in cigarettes.
Patrizia Cavazzoni, leader of the FDA's Center for Drug Evaluation and Research, is leaving the agency on Jan. 18.
FDA's Patrizia Cavazzoni to retire as CDER chief in 2nd senior official's departure in span of weeks
The FDA’s influential director of the Center for Drug Evaluation and Research, Patrizia Cavazzoni, M.D., will soon retire ...
The FDA has approved Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea in adults with obesity.
The FDA has expanded the approval of Lumryz (sodium oxybate) extended-release oral suspension to include treatment of pediatric narcolepsy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback